Table 2: Comparisons between internal and external BiVADs: utilization, mortality, length of stay, cost, and complications.
|
Internal BiVAD (n = 538) |
External BiVAD (n = 727) |
p value |
Age, years (standard deviation) |
49.5 (13.2) |
52.4 (15.2) |
0.098 |
Female, n (%) |
99 (18.4%) |
219 (30.1%) |
0.024 |
Race, n (%) |
|
|
0.03 |
White |
312 (66.9%) |
407 (61.5%) |
|
Black |
89 (19.0%) |
101 (15.2%) |
|
Hispanic |
40 (8.6%) |
55 (8.3%) |
|
Asian or Pacific Islander |
11 (2.3%) |
29 (4.4%) |
|
Native American |
5 (1.0% |
5 (0.8%) |
|
Other |
10 (2.1%) |
65 (9.9%) |
|
Missing |
72 (13.4%) |
64 (8.8%) |
|
Comorbidities, n (%) |
|
|
|
Coronary artery disease |
119 (22.1%) |
327 (44.9%) |
< 0.001 |
Myocardial infarction |
93 (17.4%) |
299 (41.2%) |
< 0.001 |
Chronic pulmonary disease |
34 (6.3%) |
78 (10.7%) |
0.236 |
Iron deficiency anemia |
70 (12.9%) |
102 (14.1%) |
0.788 |
Chronic blood loss anemia |
10 (1.9%) |
5 (0.7%) |
0.386 |
Coagulopathy |
250 (46.5%) |
356 (49.0%) |
0.765 |
Diabetes |
79 (14.7%) |
144 (19.8%) |
0.269 |
Hypertension |
148 (27.5%) |
228 (31.4%) |
0.438 |
Hypothyroidism |
15 (2.8%) |
39 (5.4%) |
0.31 |
Liver disease |
30 (5.5%) |
20 (2.8%) |
0.242 |
Lymphoma |
10 (1.9%) |
24 (3.3%) |
0.463 |
Fluid and electrolyte disorders |
356 (66.2%) |
435 (59.9%) |
0.271 |
Metastatic cancer |
0 (0.0%) |
5 (0.6%) |
0.393 |
Obesity |
65 (12.0%) |
63 (8.7%) |
0.5 |
Peripheral vascular disorders |
45 (8.4%) |
77 (10.6%) |
0.517 |
Pulmonary circulatory disorders |
0 (0.0%) |
38 (5.3%) |
0.014 |
Renal failure |
194 (36.1%) |
117 (16.1%) |
< 0.001 |
Valvular disease |
0 (0.0%) |
52 (7.2%) |
0.003 |
Insurance, n (%) |
|
|
0.768 |
Medicare |
172 (31.9%) |
219 (30.1%) |
|
Medicaid |
44 (8.3%) |
131 (18.0%) |
|
Private insurance |
298 (55.5%) |
313 (43.1%) |
|
Self pay |
9 (1.7%) |
25 (3.4%) |
|
Other |
14 (2.6%) |
39 (5.4%) |
|
Bed size of hospital, n (%) |
|
|
0.119 |
Small |
9 (1.8%) |
18 (2.5%) |
|
Medium |
43 (7.9%) |
107 (14.7%) |
|
Large |
486 (90.3%) |
601 (82.8%) |
|
Location and teaching status, n (%) |
|
|
< 0.001 |
Rural |
0 (0.0%) |
30 (4.1%) |
|
Urban non-teaching |
9 (1.7%) |
83 (11.4%) |
|
Urban Teaching |
528 (98.3%) |
614 (84.4%) |
|
Region of hospital, n (%) |
|
|
0.002 |
Northeast |
80 (14.9%) |
262 (36.0%) |
|
Midwest |
111 (20.7%) |
94 (13.0%) |
|
South |
169 (31.4%) |
200 (27.6%) |
|
West |
178 (33.0%) |
170 (23.4%) |
|
Disposition of patient, n (%) |
|
|
0.026 |
Routine |
127 (23.7%) |
80 (11.0%) |
|
Transfer to short-term hospital |
24 (4.4%) |
86 (11.8%) |
|
Transfer to nursing home |
45 (8.4%) |
64 (8.8%) |
|
Home healthcare |
98 (18.2%) |
67 (9.2%) |
|
Elective admissions, n (%) |
77 (14.3%) |
157 (21.6%) |
0.119 |
Died during hospitalization, n (%) |
244 (45.4%) |
430 (59.1%) |
0.022 |
Length of stay, days (95% CI) |
64.0 (32.0, 119.0) |
20.0 (6.0, 36.0) |
< 0.001 |
Cost, $ |
468321.3 ± 286928.0 |
208809.9 ± 134796.6 |
< 0.001 |
Complications, n (%) |
|
|
|
Transfusion |
107 (19.9%) |
185 (25.4%) |
0.396 |
Gastrointestinal bleed |
75 (14.0%) |
74 (10.1%) |
0.351 |
Hemoperitoneum |
20 (3.7%) |
15 (2.1%) |
0.414 |
Intracranial bleed |
50 (9.3%) |
59 (8.2%) |
0.738 |
Hemolytic anemia |
24 (4.5%) |
5 (0.7%) |
0.038 |
Vascular complication |
15 (2.8%) |
26 (3.6%) |
0.789 |
Acute renal failure |
460 (85.6%) |
538 (74.0%) |
0.02 |
Dialysis |
126 (23.4%) |
108 (14.9%) |
0.088 |
Mechanical complication |
15 (2.7%) |
33 (4.5%) |
0.43 |
Systemic embolism |
110 (20.4%) |
88 (12.1%) |
0.072 |
Post-op stroke or transient ischemic attack |
25 (4.6%) |
24 (3.3%) |
0.605 |
Implant-related infection |
35 (6.4%) |
23 (3.2%) |
0.432 |
Post-op wound infection |
25 (4.7%) |
20 (2.7%) |
0.405 |